Status:

COMPLETED

Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer

Lead Sponsor:

Queensland Centre for Gynaecological Cancer

Collaborating Sponsors:

Queensland Institute of Medical Research

Royal Brisbane and Women's Hospital

Conditions:

Endometrial Cancer

Eligibility:

All Genders

18-80 years

Brief Summary

The objective is to develop an organotypic model to assess the effects of obesity on the expression and methylation status of estrogen-responsive genes in endometrial cancer. Omental fat samples will ...

Eligibility Criteria

Inclusion

  • Age 18-80 years
  • Any patient having abdominal surgery (Laparoscopic or open technique) for benign conditions
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • Patients must have adequate:
  • Hematologic function: Neutrophils ≥ 1.5 x 109/L and platelets ≥ 100 x 109/L
  • Renal function: serum creatinine ≤ ULN or estimated glomerular filtration rate (eGFR) \[CKD-EPI Formula\] ≥ 60 mL/min
  • Hepatic function: serum bilirubin ≤ 1.5 x ULN and AST ≤ 2.5 x ULN and ALT≤ 2.5 x ULN
  • Physically able to undergo surgery
  • Written informed consent

Exclusion

  • Confirmed gynaecological malignancy
  • Contraindications and/or unfit for Surgery: serious concomitant systemic disorders incompatible with the study (at the discretion of the investigator);
  • Patients who are pregnant or lactating
  • Serious illness or medical condition but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia (patients with stable AF are eligible), or psychiatric illness/social situations that would limit compliance with study requirements.
  • Patients with disseminated intra-peritoneal malignancy or suspected ovarian cancer
  • HIV positive
  • Previous bariatric surgery

Key Trial Info

Start Date :

July 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2021

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT02226302

Start Date

July 1 2014

End Date

August 1 2021

Last Update

September 9 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Queen Elizabeth II Jubilee Hospital

Coopers Plains, Queensland, Australia, 4108

2

Royal Brisbane and Women's Hospital

Herston, Queensland, Australia, 4029